Home > Boards > US OTC > Medical - Healthcare > AVVAA World Health Care Products (AVVH)

NOTICE TO DISREGARD

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
nodummy Member Profile
 
Followed By 1,391
Posts 7,847
Boards Moderated 4
Alias Born 02/26/10
160x600 placeholder
nodummy   Tuesday, 08/07/18 07:39:07 PM
Re: integral post# 10974
Post # of 11032 
NOTICE TO DISREGARD

http://globenewswire.com/news-release/2018/08/07/1548593/0/en/NOTICE-TO-DISREGARD-Avvaa-World-Health-Care-Products-Inc.html

Like anybody needed proof the PR was fake.


Just because it was pulled doesn't mean that the group that did the fake PR today is off the hook. One day they will get busted and since stock manipulation is an Indictable offense hopefully they end up in handcuffs.


The fake news today was no doubt inspired by a press release that AVVH did way back in 2012 before the AVVH shell was abandoned

http://www.marketwired.com/press-release/avvaa-signs-private-label-agreement-pinksheets-avvh-1667170.htm
Quote:
avVaa Signs Private Label Agreement

By Marketwired
June 8, 2012 10:11 AM EDT

RICHMOND, VA -- (Marketwire) -- 06/08/12 -- avVaa World Health Care Products, Inc. ("avVaa" or "the Company") (PINKSHEETS: AVVH) signs private label agreement with Petonic Pet Supply, Inc. for its Dermalustre pet line products.

avVaa World Health Care Products, Inc. signed a private label agreement with Petonic Pet Supply, Inc. (www.petonicpets.com) to distribute avVaa's Dermalustre animal line under the company's own private label. Petonic Pet Supply, Inc. has a distribution agreement with Eyedot Services, Inc. in British Columbia, Canada to distribute its private label pet products to 17 stores throughout British Columbia. Petonic Pet Supply, Inc. signed a distribution agreement in May 2012 with HJG Distribution in the Maritimes and South Quebec, Canada which operates a distribution warehouse with 24 retail stores in their chain.

About avVaa World Health Care Products, Inc.
avVaa is a global biotechnology company that specializes in effective, natural, therapeutic skin care products that improve quality of life and wellbeing for consumers. avVaa's patented European skin care formulas are scientifically registered and NHP-compliant. The formulas were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Jason Price
President & Chief Operating Officer
avVaa World Health Care Products, Inc.
Phone: 1-866-864-6598
Fax: 1-866-789-9336




Rehashing old news for new fake news and using fake buyout agreements has become a common tactic used by the group that I already connected to at least 17 other stock manipulation schemes.

Here are some of the twitter pages and website this group has used to commit their securities frauds in the past:

https://penniesgonewild.com

https://twitter.com/OTCBCS

http://www.otcbitcoinstocks.com

https://twitter.com/WildPennies

https://twitter.com/PSGALERTS

https://twitter.com/StocksfortheLow

https://www.instagram.com/carlos_tsp/

https://twitter.com/@1TSP1

http://tradingstockspros.com/

A list of securities manipulated by this group using fraudulent means includes:

AVVH (fake news), SFRX (fake news), KALY (fake twitter page), TSTS (fake Nevada SOS filing), PEII (fake Nevada SOS filing), ZNTR (fake twitter page), TNKE (fake news), TRSI (fake news), BKEN (fake news), AMPG (fake news), NHPI (fake news), DKSC (fake news), WGAS (fake news), PTAH (fake news), FROT (fake news), IGBR (fake news), VRED (fake website), EMBR (fake news), and possibly others


And no surprise at all that Wildpennies/Penniesgonewild (from the fake PR group) bought AVVH stock back in May:




The fake PR today was probably done so that he could unload the rest of his position that he was still holding from May.


More about today's fake news

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142744971


And so there is a record of today's PR:

https://www.otcmarkets.com/stock/AVVH/news/story?e&id=1145279

Quote:
AVVAA WORLD HEALTH CARE PRODUCTS, INC. Agrees to Buyout term from Petonic Pet Supply Inc. for $0.02 Cents a Share.

LUMBY, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- AVVAA WORLD HEALTH CARE PRODUCTS, INC. (OTC: AVVH) avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and wellbeing for consumers. avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne.

AVVAA WORLD HEALTH CARE PRODUCTS, INC. Agreed to buyout terms from Petonic Pet Supply Inc. Official filings will be disseminated today via the U.S Securities and Exchange Commission. Petonic Pet Supply Inc. will be taking over of all companies FDA research and technology.

ABOUT AVVAA WORLD HEALTH CARE PRODUCTS, INC.

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and wellbeing for consumers. avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne.

ABOUT PETONIC PET SUPPLY INC

PeTonics mission is to provide safe, natural skin care with proven effectiveness. Our nano-fine mineral topical solution is formulated to treat and relieve the adverse effects of chronic skin, coat, mane, tail and hoof conditions/irritations. Our natural, non-toxic products improve the quality of life for domestic pets and horses.

Safe Harbor

This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Contact

Mike Dal

949-309-8147

Source: Avvaa World Health Care Products Inc.

© 2018 GlobeNewswire, Inc.






Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist